(Total Views: 499)
Posted On: 02/24/2022 9:21:09 AM
Post# of 148898
Really curious on the status of the Longhauler trial. I hope the FDA is not slow-walking our trial parameters until a BP can get their drug(s) into the race. More than that, so many people are suffering from post COVID - and if the vax side effects produce similar ailments to Longhaulers, we've got a lot of sick/injured people in this world.
Has anyone seen the numbers from the insurance company out of Indiana, and most recently, from Germany? Data from both support the same thesis, i.e., the federal health bureaucracies have been under-reporting adverse reactions to the vaccine by a factor of 10:
https://cdn.substack.com/image/fetch/f_auto,q...3x1196.png
Still amazed at the safety profile of LL, can't believe our complete lack of SAE's. Combine unprecedented safety with world-beating efficacy, it's hard to believe we're less than $50/share right now on pure potential.
Has anyone seen the numbers from the insurance company out of Indiana, and most recently, from Germany? Data from both support the same thesis, i.e., the federal health bureaucracies have been under-reporting adverse reactions to the vaccine by a factor of 10:
https://cdn.substack.com/image/fetch/f_auto,q...3x1196.png
Still amazed at the safety profile of LL, can't believe our complete lack of SAE's. Combine unprecedented safety with world-beating efficacy, it's hard to believe we're less than $50/share right now on pure potential.
(3)
(1)
Scroll down for more posts ▼